Baidu
map

JBC:DES基因触发心律失常性右心室心肌病

2012-05-25 Beyond 生物谷

畸形的结蛋白与同种类的完整蛋白质相聚合从而引发骨骼肌和心肌疾病。这项研究由RUB心脏和糖尿病中心完成,领导者为Hendrik Milting博士在与同事Würzburg和 Bielefeld。他们研究报告刊登在Journal of Biological Chemistry杂志上。 一个有缺陷的基因是足以诱发疾病 通常,在细胞内结蛋白形成稳定细丝。DES基因突变后会诱发不同的肌肉疾病。由于染色体

畸形的结蛋白与同种类的完整蛋白质相聚合从而引发骨骼肌和心肌疾病。这项研究由RUB心脏和糖尿病中心完成,领导者为Hendrik Milting博士在与同事Würzburg和 Bielefeld。他们研究报告刊登在Journal of Biological Chemistry杂志上。

一个有缺陷的基因是足以诱发疾病

通常,在细胞内结蛋白形成稳定细丝。DES基因突变后会诱发不同的肌肉疾病。由于染色体总是成对出现的,每个单元的两个不同染色体上有两个DES基因。 desminopathies打破,即使只有一个DES的基因突变。运用光敏定位显微技术(PALM),研究人员阐述了其中机制。

突变和完整蛋白质可见技术

如果一个DES基因突变,而另一个未突变是完整的,细胞会同时产生畸形和正常的蛋白质。由于不仅结蛋白的突变导致蛋白质聚集在一起,但完整的结蛋白也会促进蛋白聚集,但一个有缺陷的DES基因是足以引发疾病的。使用光敏定位显微技术,研究人员将突变体和完整的蛋白质带有不同荧光分子,然后考察蛋白质变异以及完整对疾病的作用。

进一步的研究计划

下一步,研究小组想找出DES基因触发心律失常性右心室心肌病的机制。心律失常性右心室心肌病是一种罕见的心脏肌肉病,其特点是右心室严重缺陷。

doi:10.1074/jbc.M111.313841
PMC:
PMID:

Dual-color photoactivation localization microscopy of cardiomyopathy associated desmin mutants

Andreas Brodehl, Per Niklas Hedde, Mareike Dieding, Azra Fatima, Volker Walhorn, Susan Gayda, Tomo Saric, Baerbe Klauke, Jan Gummert, Dario Anselmetti, et al.

Mutations in the DES gene coding for the intermediate filament protein desmin may cause skeletal and cardiac myopathies, which are frequently characterized by cytoplasmic aggregates of desmin and associated proteins at the cellular level. By atomic force microscopy we demonstrated filament formation defects of desmin mutants, associated with arrhythmogenic right ventricular cardio-myopathy. To understand the pathogenesis of this disease, it is essential to analyze desmin filament structures under conditions in which both healthy and mutant desmin are expressed at equimolar levels mimicking an in vivo situation. Here, we applied dual-color photoactivation localization microscopy using photoactivatable fluorescent proteins genetically fused to desmin and characterized the heterozygous status in living cells lacking endogenous desmin. In addition, we applied fluorescence resonance energy transfer to unravel short-distance structural patterns of desmin mutants in filaments. For the first time, we present consistent high resolution data on the structural effects of five heterozygous desmin mutations on filament formation in vitro and in living cells. Our results may contribute to the molecular understanding of the pathological filament formation defects of heterozygous DES mutations in cardiomyopathies.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036368, encodeId=b0cc2036368a5, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Nov 18 11:58:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543736, encodeId=0c121543e3663, content=<a href='/topic/show?id=52d93862e06' target=_blank style='color:#2F92EE;'>#右心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38627, encryptionId=52d93862e06, topicName=右心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18d13610637, createdName=124988c7m99暂无昵称, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558482, encodeId=a9cd15584827e, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564491, encodeId=479f1564491ac, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622188, encodeId=8d891622188ec, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=)]
    2012-11-18 lily1616
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036368, encodeId=b0cc2036368a5, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Nov 18 11:58:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543736, encodeId=0c121543e3663, content=<a href='/topic/show?id=52d93862e06' target=_blank style='color:#2F92EE;'>#右心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38627, encryptionId=52d93862e06, topicName=右心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18d13610637, createdName=124988c7m99暂无昵称, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558482, encodeId=a9cd15584827e, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564491, encodeId=479f1564491ac, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622188, encodeId=8d891622188ec, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2036368, encodeId=b0cc2036368a5, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Nov 18 11:58:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543736, encodeId=0c121543e3663, content=<a href='/topic/show?id=52d93862e06' target=_blank style='color:#2F92EE;'>#右心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38627, encryptionId=52d93862e06, topicName=右心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18d13610637, createdName=124988c7m99暂无昵称, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558482, encodeId=a9cd15584827e, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564491, encodeId=479f1564491ac, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622188, encodeId=8d891622188ec, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=)]
    2012-05-27 fusion
  4. [GetPortalCommentsPageByObjectIdResponse(id=2036368, encodeId=b0cc2036368a5, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Nov 18 11:58:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543736, encodeId=0c121543e3663, content=<a href='/topic/show?id=52d93862e06' target=_blank style='color:#2F92EE;'>#右心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38627, encryptionId=52d93862e06, topicName=右心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18d13610637, createdName=124988c7m99暂无昵称, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558482, encodeId=a9cd15584827e, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564491, encodeId=479f1564491ac, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622188, encodeId=8d891622188ec, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=)]
    2012-05-27 fusion
  5. [GetPortalCommentsPageByObjectIdResponse(id=2036368, encodeId=b0cc2036368a5, content=<a href='/topic/show?id=0c901025932' target=_blank style='color:#2F92EE;'>#JBC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10259, encryptionId=0c901025932, topicName=JBC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sun Nov 18 11:58:00 CST 2012, time=2012-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543736, encodeId=0c121543e3663, content=<a href='/topic/show?id=52d93862e06' target=_blank style='color:#2F92EE;'>#右心室#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38627, encryptionId=52d93862e06, topicName=右心室)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f18d13610637, createdName=124988c7m99暂无昵称, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558482, encodeId=a9cd15584827e, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564491, encodeId=479f1564491ac, content=<a href='/topic/show?id=b68a586365' target=_blank style='color:#2F92EE;'>#DES#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5863, encryptionId=b68a586365, topicName=DES)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=432c14994935, createdName=fusion, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622188, encodeId=8d891622188ec, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sun May 27 10:58:00 CST 2012, time=2012-05-27, status=1, ipAttribution=)]

相关资讯

辣椒可能有益心脏

  2012年3月27日,美国化学学会(ACS)第243届全国会议与博览会报告,辣椒是对心脏有益的食物、有潜力预防这种发达国家的头号死因。     报告人香港中文大学食品与营养科学教授陈震宇说:“我们得出结论,即辣椒碱在改善与心脏和血管健康有关的一批因素方面起到了有益作用,但是我们肯定不会推荐人们开始过量食用辣椒。良好的饮食在于平衡。记住,辣椒不能替代被证明有益的处方药。然而,对于那些喜欢火辣味

置入心脏节律装置患者持续抗凝或较肝素过渡策略更安全

  美国学者的一项荟萃分析表明,对于置入心脏节律装置的患者,持续抗凝(AC)似乎较肝素过渡策略(HBS)更为安全。论文于2012年4月24日在线发表于《循环》(Circulation)杂志。   置入心脏节律装置的患者多伴有须抗血小板(AP)和(或)AC治疗的疾病。对于伴有中/高危血栓形成风险的抗凝患者,当前指南推荐应用HBS。数项研究报告,持续口服抗凝的出血风险低于HBS。目前,尚不清楚

Psychol. Bull.:哈佛大学研究发现:乐观有益心脏健康

美国哈佛大学研究发现,乐观开朗、感觉生活充满希望的人患心脏病或中风的风险低。 研究报告由最新一期《心理学通报》月刊网络版发表。 存在关联 哈佛大学公共卫生学院研究人员分析先前200个研究,这些研究都试图找出心理健康与心血管健康的关系。所有研究采用问卷调查和评分的方式,给调查对象的性格、是否乐观、生活满意度等打分。 美联社引述研究负责人朱莉娅·贝姆的话报道:“不消极和积极不是一回事……我们发

人体生物可降解冠脉支架长期安全性获证据

     日本研究者4月16日在《循环》(Circulation)在线发表了首个置入人体的生物可降解聚乳酸冠脉支架——Igaki-Tamai支架的长期安全性结果。>10年的总随访结果显示,在无支架回缩和血管重构情况下,该支架的主要不良心脏事件(MACE)和支架血栓形成率可以接受,提示该支架长期应用是安全的。   50例患者于1998-2000年择期置入Igaki-

Nature:美科学家发现心脏修复的新策略

5月13日,Nature在线发表了德克萨斯大学西南医学中心等多家科研单位的一篇题为Heart repair by reprogramming non-myocytes with cardiac transcription factors的文章,研究表明:在体内或体外通过四种心脏转录因子(GATA4,HAND2, MEF2C and TBX5)可以将成年鼠纤维原细胞重编程为功能性的心脏样肌细胞。

Circulation:无症状预激综合征常规有创干预受质疑

  加拿大学者的一项荟萃分析表明,大部分无症状性预激综合征患者的心脏猝死发病率较低,室上性心动过速(SVT)风险亦较低,因此可能无需常规有创治疗。论文于2012年4月24日在线发表于《循环》(Circulation)杂志。   在伴有无症状性预激的患者中,心脏猝死的发病率和其风险管理尚有待明确。研究者对EMBASE和Medline数据库中的前瞻性、回顾性、随机或队列研究进行了系统检索,并纳入了涉

Baidu
map
Baidu
map
Baidu
map